Repligen (RGEN) EBITDA Margin Growth (3y) (2013 - 2026)
Powered by 
Analysis
Repligen (RGEN) EBITDA Margin Growth (3y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 223.99 Bn | 219.93 Bn | 8.34 Bn | 263.00 |
| 2 | Danaher | 141.56 Bn | 137.22 Bn | 3.61 Bn | -168.00 |
| 3 | Agilent Technologies | 40.36 Bn | 38.60 Bn | 1.04 Bn | 1,569.00 |
| 4 | Illumina | 30.41 Bn | 29.24 Bn | 770.00 Mn | 2,862.00 |
| 5 | Revvity | 13.50 Bn | 12.48 Bn | 416.87 Mn | 123.00 |
| 6 | Bio-Techne | 11.25 Bn | 10.98 Bn | 211.39 Mn | -825.00 |
| 7 | Bio-Rad Laboratories | 9.88 Bn | 8.26 Bn | 345.80 Mn | -201.00 |
| 8 | Repligen | 9.29 Bn | 8.28 Bn | 110.04 Mn | -527.00 |
| 9 | 10x Genomics | 8.62 Bn | 8.06 Bn | 112.50 Mn | 3,021.00 |
| 10 | Bruker | 8.16 Bn | 7.94 Bn | 416.00 Mn | -2,043.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -527.00 |
| Mar 31, 2026 | -17.00 |
| Dec 31, 2025 | -1,712.00 |
| Sep 30, 2025 | -1,732.00 |
| Jun 30, 2025 | -2,280.00 |
| Mar 31, 2025 | -2,518.00 |
| Dec 31, 2024 | -4,185.00 |
| Sep 30, 2024 | -3,042.00 |
| Jun 30, 2024 | -2,616.00 |
| Mar 31, 2024 | -2,302.00 |
| Dec 31, 2023 | -1,011.00 |
| Sep 30, 2023 | -1,896.00 |
| Jun 30, 2023 | -1,022.00 |
| Mar 31, 2023 | -727.00 |
| Dec 31, 2022 | 1,767.00 |
| Sep 30, 2022 | 1,477.00 |
| Jun 30, 2022 | 1,479.00 |
| Mar 31, 2022 | 1,065.00 |
| Dec 31, 2021 | 495.00 |
| Sep 30, 2021 | 944.00 |